Dominantly inherited demyelinating neuropathies, known as Charcot-Marie-Tooth disease type 1 (CMTI), are among the most common inherited neurological diseases. CMTI is caused by mutations in one of several genes that are expressed by myelinating Schwann cells, including PMP22, MPZ, and GJBJ. Although demyelination is the first pathological consequence, axonal loss rather than demyelination per se, is the main cause of neurologic disability. In this grant, we will evaluate the consequences of disrupted axon-Schwann cell interactions in demyelinating neuropathies, by determining whether demyelination and remyelination reorganize the axonal membrane in (i) several animal models of inherited demyelinating neuropathy, and in (ii) an animal model of acute demyelination (after lysolecithin injection into the sciatic nerve). In this way, we will determine whether different genetic causes of demyelination have similar effects on the molecular organization of axonal membranes, and the temporal order in which the molecular components of nodes, paranodes, and juxtaparanodes are disassembled by demyelination and reassembled during remyelination. We will also determine whether axonal loss in demyelinating neuropathies can be ameliorated in two ways-by breeding Mpz/Po-null and Pmp22-null mice with either Wids or transgenic mice in which glial-derived neurotrophic factor (GDNF) is overexpressed in muscle. If expressing the Wlds gene or the GDNF-transgene preserves axons Mpz/Po-null and Pmp22-null mice, this will provide proof of the concept that therapies directed at neurons rather than myelinating Schwann cells can be effective treatments for inherited demyelinating neuropathies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS043174-04
Application #
6872944
Study Section
Special Emphasis Panel (ZRG1-MDCN-2 (01))
Program Officer
Porter, John D
Project Start
2002-04-01
Project End
2006-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
4
Fiscal Year
2005
Total Cost
$338,794
Indirect Cost
Name
University of Pennsylvania
Department
Neurology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Lassuthova, Petra; Rebelo, Adriana P; Ravenscroft, Gianina et al. (2018) Mutations in ATP1A1 Cause Dominant Charcot-Marie-Tooth Type 2. Am J Hum Genet 102:505-514
King, Chih H; Lancaster, Eric; Salomon, Daniela et al. (2014) Kv7.2 regulates the function of peripheral sensory neurons. J Comp Neurol 522:3262-80
King, Chih H; Scherer, Steven S (2012) Kv7.5 is the primary Kv7 subunit expressed in C-fibers. J Comp Neurol 520:1940-50
Lancaster, Eric; Huijbers, Maartje G M; Bar, Vered et al. (2011) Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 69:303-11
Shroff, Seema; Mierzwa, Amanda; Scherer, Steven S et al. (2011) Paranodal permeability in ""myelin mutants"". Glia 59:1447-57
Potter, Kathleen A; Kern, Michael J; Fullbright, George et al. (2011) Central nervous system dysfunction in a mouse model of FA2H deficiency. Glia 59:1009-21
Lancaster, Eric; Elman, Lauren B; Scherer, Steven S (2010) A patient with neurofibromatosis type 1 and Charcot-Marie-Tooth disease type 1B. Muscle Nerve 41:555-8
Vavlitou, Natalie; Sargiannidou, Irene; Markoullis, Kyriaki et al. (2010) Axonal pathology precedes demyelination in a mouse model of X-linked demyelinating/type I Charcot-Marie Tooth neuropathy. J Neuropathol Exp Neurol 69:945-58
Yum, Sabrina W; Zhang, Junxian; Mo, Katie et al. (2009) A novel recessive Nefl mutation causes a severe, early-onset axonal neuropathy. Ann Neurol 66:759-70
Pedrola, Laia; Espert, Antonio; Valdes-Sanchez, Teresa et al. (2008) Cell expression of GDAP1 in the nervous system and pathogenesis of Charcot-Marie-Tooth type 4A disease. J Cell Mol Med 12:679-89

Showing the most recent 10 out of 18 publications